Hainan Poly Pharm Co Ltd (300630) — Capital Reinvestment Ratio
Latest as of June 2023:
4.22x
Hainan Poly Pharm Co Ltd (300630) has a Capital Reinvestment Ratio of 4.22x as of June 2023, meaning it reinvests 4% of its operating cash flow (CN¥44.82 Million) in capital expenditures (CN¥189.19 Million). See free cash flow generation of Hainan Poly Pharm Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
4.22x
Capex / Operating Cash Flow
Operating Cash Flow
CN¥44.82 Million
CNY
Capital Expenditures
CN¥189.19 Million
CNY
Data as of
Jun 2023
Most recent filing
Hainan Poly Pharm Co Ltd Capital Reinvestment Ratio (2016–2023)
This chart tracks Hainan Poly Pharm Co Ltd's Capital Reinvestment Ratio across 8 annual periods.
Annual Capital Reinvestment Ratio for Hainan Poly Pharm Co Ltd (2016–2023)
Year-by-year Capital Reinvestment Ratio for Hainan Poly Pharm Co Ltd from 2016 to 2023. For live market cap and broader valuation context, see 300630 company net worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 4.86x | CN¥112.72 Million | CN¥548.15 Million | ▲ +150.6% |
| 2022 | 1.94x | CN¥534.29 Million | CN¥1.04 Billion | ▼ -62.1% |
| 2021 | 5.12x | CN¥157.03 Million | CN¥803.78 Million | ▲ +103.2% |
| 2020 | 2.52x | CN¥332.08 Million | CN¥836.54 Million | ▲ +34.8% |
| 2019 | 1.87x | CN¥215.37 Million | CN¥402.51 Million | ▼ -29.7% |
| 2018 | 2.66x | CN¥94.79 Million | CN¥251.99 Million | ▲ +42.8% |
| 2017 | 1.86x | CN¥93.79 Million | CN¥174.58 Million | ▲ +13.3% |
| 2016 | 1.64x | CN¥55.53 Million | CN¥91.19 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow